In: European Heart Journal, 2004, vol. 25, no. 7, p. 565-570
|
In: European Heart Journal, 2010, vol. 31, no. 6, p. 639-639
|
In: European Heart Journal, 2010, vol. 31, no. 10, p. 1197-1204
|
In: European Heart Journal, 2006, vol. 27, no. 13, p. 1571-1578
|
In: European Heart Journal, 2004, vol. 25, no. 12, p. 1014-1020
|
In: European Heart Journal, 2005, vol. 26, no. 12, p. 1180-1187
|
In: European Heart Journal, 2012, vol. 33, no. 5, p. 614-621
|
In: Clinical Infectious Diseases, 1999, vol. 28, no. 4, p. 933-934
|
In: European Heart Journal, 2006, vol. 27, no. 2, p. 157-165
|
In: Journal of the American College of Cardiology: Cardiovascular Interventions, 2011, vol. 4, no. 6, p. 672-682
Objectives: This study sought to compare the efficacy of passive stent coating with titanium-nitride-oxide (TiNO) with drug-eluting stents releasing zotarolimus (ZES) (Endeavor, Medtronic, Minneapolis, Minnesota).Background: Stent coating with TiNO has been shown to reduce restenosis compared with bare-metal stents in experimental and clinical studies.Methods: In an assessor-blind noninferiority...
|